PRX-5 program (Proximagen)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePRX-5 program (Proximagen)
Drug Alias NamePRX-5 program (Proximagen)dopamine D1 agonists (Proximagen)PRX-5PRX-5007
ClassificationSmall molecules
Mechanisms of ActionDopamine D1 receptor agonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsCognition DisordersParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProximagen Group plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProximagen Group plc
Active IndicationsN/A
Inactive IndicationsCognition DisordersParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A